153 related articles for article (PubMed ID: 17513310)
1. A preliminary experimental study of boron neutron capture therapy for malignant tumors spreading in thoracic cavity.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Jpn J Clin Oncol; 2007 Apr; 37(4):245-9. PubMed ID: 17513310
[TBL] [Abstract][Full Text] [Related]
2. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
3. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
4. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
5. Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma.
Suzuki M; Tanaka H; Sakurai Y; Kashino G; Yong L; Masunaga S; Kinashi Y; Mitsumoto T; Yajima S; Tsutsui H; Sato T; Maruhashi A; Ono K
Radiother Oncol; 2009 Jul; 92(1):89-95. PubMed ID: 19329206
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
[TBL] [Abstract][Full Text] [Related]
7. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
[TBL] [Abstract][Full Text] [Related]
8. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
[TBL] [Abstract][Full Text] [Related]
9. A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).
Suzuki M; Endo K; Satoh H; Sakurai Y; Kumada H; Kimura H; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Radiother Oncol; 2008 Aug; 88(2):192-5. PubMed ID: 18653257
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):953-8. PubMed ID: 15308174
[TBL] [Abstract][Full Text] [Related]
11. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model.
Heber EM; Aromando RF; Trivillin VA; Itoiz ME; Nigg DW; Kreimann EL; Schwint AE
Arch Oral Biol; 2007 Mar; 52(3):273-9. PubMed ID: 17137553
[TBL] [Abstract][Full Text] [Related]
16. Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors.
Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Ono K; Maruhashi A; Kato I; Fuwa N; Hiratsuka J; Imahori Y
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1523-7. PubMed ID: 17056200
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.
Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
19. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
20. Early effects of boron neutron capture therapy on rat glioma models.
Nakagawa N; Akai F; Fukawa N; Fujita Y; Suzuki M; Ono K; Taneda M
Brain Tumor Pathol; 2007; 24(1):7-13. PubMed ID: 18095138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
